Back
Eversource Energy Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
28
ES
Eversource Energy
Last Price:
$61.11
Seasonality Move:
1.28%
Sell
43
ALNY
Alnylam Pharmaceuticals
Last Price:
$268.29
Seasonality Move:
7.6%
Sell
28
Eversource Energy (ES)
is a Sell
Is Eversource Energy a Buy, Sell or Hold?
-
The current Eversource Energy [ES] share price is $61.12. The Score for ES is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
ES is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $268.46. The Score for ALNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ES Stock Price Chart
What is Eversource Energy's stock price today?
-
The Eversource Energy share price today is $61.12Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ES is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $268.46The current trend is moderately bullish and ALNY is experiencing slight buying pressure.
ES Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 16.5 | Buy |
| Relative Strength Index (14 RSI): | 51.99 | Buy |
| Chaikin Money Flow: | 290509 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (59.73 - 62.73) | Sell |
| Bollinger Bands (100): | (57.55 - 62.61) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.41 | Buy |
| Relative Strength Index (14 RSI): | 55.64 | Buy |
| Chaikin Money Flow: | 78938 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (238.82 - 268.04) | Buy |
| Bollinger Bands (100): | (240.65 - 270.25) | Buy |
ES Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.66 | Buy |
| 20-day SMA: | 60.72 | Buy |
| 50-day SMA: | 59.95 | Buy |
| 200-day SMA: | 61.91 | Sell |
| 8-day EMA: | 50.07 | Buy |
| 20-day EMA: | 30.47 | Buy |
| 50-day EMA: | 14.78 | Buy |
| 200-day EMA: | 4.09 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 271.33 | Sell |
| 20-day SMA: | 255.41 | Buy |
| 50-day SMA: | 259.88 | Buy |
| 200-day SMA: | 253.94 | Buy |
| 8-day EMA: | 268.64 | Sell |
| 20-day EMA: | 261.32 | Buy |
| 50-day EMA: | 257.88 | Buy |
| 200-day EMA: | 244.57 | Buy |
Eversource Energy Earnings Growth & ES Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.49 per share, an increase this year of $0.20 per share, and an increase next year of $0.28 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
Eversource Energy Technical Analysis
| Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||